COVID-19 pandemic in Nepal

Spread and timeline

Transmission initially involved travelers and cross-border movement, with later surges associated with returning migrant workers, easing of restrictions, and the emergence of more transmissible variants. The country experienced periods of relatively low detected transmission and then sharper peaks; these shifts led to intermittent local and national measures to limit spread. Testing capacity expanded over time from centralized laboratories to more regional facilities using RT-PCR and antigen tests.

Government and public-health response

Authorities used a combination of measures to try to limit transmission: border controls, quarantine and isolation centers, contact tracing, mask mandates, and restrictions on large gatherings. A national lockdown was imposed in 2020 and reintroduced in modified forms during subsequent surges. Health-care facilities increased preparedness for hospital admissions, though many areas faced shortages of equipment and trained staff.

Vaccination and variants

Vaccination campaigns began after vaccines became available internationally, with doses arriving through bilateral donations and global initiatives. The rollout prioritized health workers, older adults, and vulnerable groups before expanding to the wider population. The appearance of variants of concern — notably more transmissible strains — influenced public-health planning and accelerated efforts to vaccinate and boost coverage.

Socioeconomic impact

The pandemic affected livelihoods, especially in tourism, hospitality and among migrant workers who remit income from abroad. Remote communities faced disruptions to routine health services and education. Supply-chain interruptions and periods of restricted movement compounded economic hardship for many households.

Challenges, adaptations and lessons

Nepal confronted challenges including limited intensive-care capacity, oxygen supply shortages during intense waves, and difficulties in reaching remote populations. At the same time, the crisis spurred investments in testing and surveillance, community health outreach, and international cooperation to secure vaccines and medical supplies. Ongoing emphasis on vaccination, surveillance and health-system strengthening remains central to managing future respiratory disease threats.